πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 980 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7601718

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7598277

Inhibitors of p38

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7598412

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7598245

Aminotriazole compounds useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7592368

Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7592340

Quinoxalines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7589214

Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7582641

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7569604

Heterocyclic derivatives for modulation of calcium channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7569591

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7563795

Phenyl-piperazine derivatives as modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7557106

Substituted pyrimidines useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7553852

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7553855

Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7547794

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7531570

Treatment of diseases using ICE inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7531556

Compositions useful as inhibitors of rock and other protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7531536

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7531523

Sodium channel protein type III alpha-subunit splice variant

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7527952

Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7528142

Aminopyrimidines useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7528138

Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7517987

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7514448

Azaindoles useful as inhibitors of rock and other protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted